《大行報告》麥格理削華虹(01347.HK)目標價至7.08元 第四季指引非常疲弱
麥格理發表評級報告指,華虹(01347.HK)第三季業績表現疲軟,其收入按季及按年跌10%,平均售價按季跌10%,毛利率由第二季的28%跌至16%。該行表示,管理層指引非常疲弱,第四季收入預測4.75億美元,按年跌25%,毛利率指引3.5%,意味著毛利按季跌83%,按年跌93%。管理層解釋,毛利率下跌主要是平均售價下跌及庫存銷帳,這亦意味著第四季或出現營運虧損。
該行表示,將公司今年、明年及2025年營運利潤預測下調37%、114%及53%,而純利預測則分別下調24%、55%及33%。該行將其目標價由18.84元下調至7.08元,維持其評級為「跑輸大市」。(ca/cy)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.